Probing ligand binding modes of Mycobacterium tuberculosis MurC ligase by molecular modeling, dynamics simulation and docking.
Multi drug resistance capacity for Mycobacterium tuberculosis (MDR-Mtb) demands the profound need for developing new anti-tuberculosis drugs. The present work is on Mtb-MurC ligase, which is an enzyme involved in biosynthesis of peptidoglycan, a component of Mtb cell wall. In this paper the 3-D structure of Mtb-MurC has been constructed using the templates 1GQQ and 1P31. Structural refinement and energy minimization of the predicted Mtb-MurC ligase model has been carried out by molecular dynamics. The streochemical check failures in the energy minimized model have been evaluated through Procheck, Whatif ProSA, and Verify 3D. Further torsion angles for the side chains of amino acid residues of the developed model were determined using Predictor. Docking analysis of Mtb-MurC model with ligands and natural substrates enabled us to identify specific residues viz. Gly125, Lys126, Arg331, and Arg332, within the Mtb-MurC binding pocket to play an important role in ligand and substrate binding affinity and selectivity. The availability of Mtb-MurC ligase built model, together with insights gained from docking analysis will promote the rational design of potent and selective Mtb-MurC ligase inhibitors as antituberculosis therapeutics.
Anuradha
C M
CM
Department of Biotechnology, University College of Engineering and technology, Anantapur, India.
Mulakayala
Chaitanya
C
Babajan
Banaganapalli
B
Naveen
M
M
Rajasekhar
Chikati
C
Kumar
Chitta Suresh
CS
D000995:Antitubercular Agents / Q000737:chemistry*; D001665:Binding Sites; D002473:Cell Wall / Q000201:enzymology; D018360:Crystallography, X-Ray; D018432:Drug Resistance, Multiple; D006801:Humans; D007538:Isoniazid / Q000737:chemistry; D008024:Ligands; D008958:Models, Molecular; D008968:Molecular Conformation; D056004:Molecular Dynamics Simulation; D009169:Mycobacterium tuberculosis / Q000737:chemistry*; D010453:Peptide Synthases / Q000037:antagonists & inhibitors / Q000737:chemistry*; D014376:Tuberculosis / Q000628:therapy
D000995:Antitubercular Agents; D008024:Ligands; D010453:Peptide Synthases; C053379:UDP-N-acetylmuramoylalanine-D-glutamate ligase; D007538:Isoniazid